Search

Your search keyword '"Montalescot, G."' showing total 43 results

Search Constraints

Start Over You searched for: Author "Montalescot, G." Remove constraint Author: "Montalescot, G." Language undetermined Remove constraint Language: undetermined
43 results on '"Montalescot, G."'

Search Results

1. One-Year Outcomes after PCI Strategies in Cardiogenic Shock

2. Assessing the cardiology community position on transradial intervention and the use of bivalirudin in patients with acute coronary syndrome undergoing invasive management: results of an EAPCI survey

3. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)

4. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

5. Wytyczne ESC dotyczące postępowania w stabilnej chorobie wieńcowej w 2013 roku

6. Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

7. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization

8. Effect of Pre-Hospital Ticagrelor During the First 24 h After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction The ATLANTIC-H-24 Analysis

9. Early versus Delayed, Provisional Eptifibatide in Acute Coronary Syndromes

10. P2Y12 inhibitors

11. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

12. Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis

13. Revascularization strategies in acute myocardial infarction: a meta-analysis

14. [Expert consensus document on the use of antiplatelet agents]

15. 2014 ESC/EACTS Guidelines on myocardial revascularization

16. 2014 ESC/EACTS Guidelines on myocardial revascularization

17. Rationale and design of the GRACE (Global Registry of Acute Coronary Events) Project: A multinational registry of patients hospitalized with acute coronary syndromes

18. Value of Antiplatelet Therapy in Preventing Thrombotic Events in Generalized Vascular Disease

19. The additional value of patient-reported health status in predicting 1-year mortality after invasive coronary procedures: a report from the Euro Heart Survey on Coronary Revascularisation

20. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization

21. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

22. Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

23. on behalf of the FINESSE angiographic sub-study investigators. Evaluation of Infarct Related Coronary Artery Patency and Microcirculatory Function after Facilitated Percutaneous Primary Coronary Angioplasty. The FINESSE-ANGIO (Facilitated Intervention With Enhanced Reperfusion Speed to Stop Events Angiographic) Study

24. Comparison of the efficacy of rosuvastatin versus atorvastatin in reducing apolipoprotein B/apolipoprotein A-1 ratio in patients with acute coronary syndrome: results of the CENTAURUS study

25. Interactions between heparins, glycoprotein IIb/IIIa antagonists, and coronary intervention. The Global Registry of Acute Coronary Events (GRACE)

26. Facilitated percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: Results from the prematurely terminated ADdressing the Value of facilitated ANgioplasty after Combination therapy or Eptifibatide, monotherapy in acute Myocardial Infarction (ADVANCE MI) trial

27. The clopidogrel in unstable angina to prevent Recurrent Events (CURE) trial programme - Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease

30. Clinical practice guidelines of the ESC on myocardial revascularization, 2014,Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014

31. Clinical practice guidelines of the ESC on myocardial revascularization, 2014 | Guía de práctica clínica de la ESC sobre revascularización miocárdica, 2014

33. Comparison of fondaparinux and enoxaparin in acute coronary syndromes

35. Management of anti-vitamin K overdose, situations at hemorrhagic risk and hemorrhagic accidents among patients treated with anti-vitamin K in urban and hospital setting: Introduction,Prise en charge des surdosages en antivitamines K, des situations à risque hémorrahique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier: Introduction

38. Management of anti-vitamin K overdose, situations at hemorrhagic risk and hemorrhagic accidents among patients treated with anti-vitamin K in urban and hospital setting: Introduction | Prise en charge des surdosages en antivitamines K, des situations à risque hémorrahique et des accidents hémorragiques chez les patients traités par antivitamines K en ville et en milieu hospitalier: Introduction

40. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

41. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

42. Impact of presentation and transfer delays on complete ST-segment resolution before primary percutaneous coronary intervention: insights from the ATLANTIC trial

43. Corrigendum to: '2013 ESC guidelines on the management of stable coronary artery disease'

Catalog

Books, media, physical & digital resources